It is our mission to secure Indiana’s position as a global leader in life sciences by advocating, connecting, promoting, and delivering tangible benefits on behalf of our diverse corporate members.
IHIF members are eligible for discounts and savings on a wide variety of products and services geared towards life sciences companies and general business needs. From lab supplies and insurance to office supplies and credit cards, there is something here for most every company. Explore your options and enjoy the benefits of being an IHIF member!
BioFutures 2022 – Closing Soon!

Reserve Your Ad Space Now

The Indiana Health Industry Forum (IHIF), in partnership with Indianapolis Business Journal, will publish the 2022 BioFutures Magazine, a round-up of the latest news from the state’s thriving health and life sciences sectors.

This year’s BioFutures Magazine will be inserted in the March 18, 2022, issue of IBJ and will reach business decision makers throughout central Indiana and beyond. BioFutures is also the primary marketing piece used by IHIF as it promotes Indiana’s health science sector at events locally, nationally, and around the world.

Learn More and download rate flyer
New BIO Business Solutions Program Partner
AON Human Capital Services
Open to Eligible IHIF Members
Aon has partnered with the Biotechnology Innovation Organization (BIO) and IHIF to provide members with a wide range of human capital services spanning the areas of employee rewards, sales force compensation and effectiveness, talent assessment, total rewards strategy and optimization, and workforce analytics (e.g., DE&I metrics and pay equity).

Through the BIO Business Solutions® Program, IHIF members will receive a 10% discount on consulting fees for new client engagements in the following practice areas:

Employee rewards (e.g., salary structure and bonus plan design);
Sales force compensation and effectiveness;
Talent assessment tools and strategy;
Total rewards strategy and optimization; and
Workforce analytics (e.g., DE&I metrics and pay equity).

Please note: Engagements in the areas of corporate governance, equity plan design, and executive compensation are not included.

•7.5% discount on compensation survey participation, including McLagan and Radford products. This offer is only available to first-time buyers who have not previously participated in any Aonsurvey.
•Access to select Aon articles and research, including proprietary insights from the Radford Global Compensation Database.

For initial inquiries, visit or contact for more information.
New Business Solutions Program Partner - Mercer -
BIO Health Plans Now Available
Open to Eligible IHIF Members
Through our partnership with the Biotechnology Innovation Organization (BIO), IHIF is excited to offer our members access to NEW & IMPROVED health care options that will be available for an effective date of January 1, 2022!
Quoting starting on 11/1 for all states (except Alaska, Wyoming and Hawaii) for a January 1, 2022 effective date.
With these NEW BIO Health Plans you can offer medical, dental, vision, and life insurance plans with more choices and convenience:
·   New Multiple-Carrier Quoting – We’ll shop several well-known local and national health carriers, discuss your needs and find the best plan options.
·   New Lower Minimum – Enrollment for as few as 2 employees.
·   Easy Online Enrollment – Paperless enrollment for you and your employees.
·   HR Administrative Portal – Helps you easily manage multiple carriers and plans.
BIO understands the unique health care needs of small to medium-sized companies and their families, and we are committed to your success.
Visit to learn more or get a quote! Questions? Call 855-698-1570.

BIO Health Plans are fully ACA-compliant. Please check map on the website for current state eligibility and requirements.
Program Administered by Mercer Health & Benefits Administration LLC
AR Insurance License #100102691 | CA Insurance License #0G39709
In CA d/b/a Mercer Health & Benefits Insurance Services LLC
Interested in this opportunity but not an IHIF Member? Join today! BIO Business Solutions eligible memberships start at just $300/year! Learn about other BIO Business Solutions savings programs here.
Special offer for IHIF Members from MassBioEd

MassBioEd has launched a new schedule of Professional Training Courses, which includes new offerings! Taught by expert instructors, MassBioEd’s online courses are tailored to ensure the content and format maximize interaction and engagement. MassBioEd is extending the MassBio Member discount to member companies of associations part of the Council of State Bioscience Associations (CSBA).

To request the discount, please register HERE using the “1” member rate and selecting IHIF as an “Other State Association”.
COVID Updates
The Global Pandemic Prevention and Biodefense Center is setting up a bank of antibodies for some 100 viruses with pandemic potential, including coronaviruses, influenza viruses and flaviviruses and is seeking investments and support from governments, the biotechnology industry, research universities and philanthropists. The bank will open next year near the NIH in Maryland, and researchers will also look for ways to reduce antibody development and manufacturing costs and to facilitate distribution and administration, leaders say.
Acon FlowFlex COVID-19 SARS-CoV-2 Antigen Test

COVID-19 Antigen Home Test Package, a rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens

  • For self-testing use under an Emergency Use Authorization (EUA) only
  • Aids in identifying individuals suspected of an active COVID-19 infection by their healthcare provider within the first seven days of the onset of symptoms
  • Nasal swab specimens
  • Results in 15 Minutes
  • Excellent performance compared to molecular methods
  • Room temperature storage
  • Available to ship December 6 based on availability and stock

Please contact your local Avantor representative for ordering details. Not sure who to contact? Let IHIF connect you!
IHIF's Policy Corner
What We're Following at Home and on the Hill

IHIF Actions:
  • Continuing conversations opposing drug pricing provisions in the Build Back Better legislation
  • Continuing support for prioritization of semiconductor chips for medical use
  • Meetings with Indiana legislators and staff members
  • Preparing for 2022 Session of the Indiana General Assembly
If we don’t act, AMR could be the next pandemic
Already, 700,000 die from drug-resistant infections each year worldwide—and without action, antimicrobial resistance (AMR) could be the next pandemic. As we start World Antimicrobial Awareness Week, we explore the problem and possible solutions

Remind me—what’s AMR? Antimicrobial resistance is when bacteria, viruses, fungi, and parasites no longer respond to medicines, making infections harder to treat. 

Without new antibiotics and antimicrobials, AMR could kill 10 million people per year by 2050—more than the number of people who die annually from cancer.

AMR affects everyone, but especially the most vulnerable patients, as we explain in a new exclusive story

Learn more about AMR and World Antimicrobial Awareness Week—read our full story.
(Source: Good Day BIO 11/18/21)

Read/Listen: Antimicrobial Resistance: The Silent Pandemic  (Source: I Am BIO 11/23/21)
U.S. Sen. Todd Young, an Indiana Republican, is among six GOP senators on the U.S. Senate Committee on Commerce, Science, and Transportation who filed the FREIGHT Act. Read More (Source: Indianapolis Business Journal)
Reps. Diana DeGette, D-Colo., and Fred Upton, R-Mich., introduced legislation known as Cures 2.0, a follow-up to the 21st Century Cures Act that would provide funding to the FDA and CMS and establish the $6.5 billion Advanced Research Projects Agency for Health to study diabetes, Alzheimer's disease and other illnesses. The legislation would make changes to the FDA's regenerative medicine advanced therapy and breakthrough therapy designation programs, require Medicare to expedite coverage of breakthrough medical devices, and eliminate geographic and originating site restrictions for telehealth services, among other provisions.
Full Story: Regulatory Focus (11/16), FierceHealthcare (11/16)  
Member News
Genezen Continues Life Sciences Growth in Fishers
The life sciences sector in Hamilton County continues to grow. Fishers-based cell and gene therapy contract development and manufacturing organization Genezen has announced plans to invest $40 million to expand its Fishers facility and create up to 62 jobs by the end of 2023. The company says the 75,000-square-foot addition will triple its current footprint. Read More (Source: Inside Indiana Business)

IHIF Congratulates Genezen on the recent rIbbon cutting for their new manufacturing facility in Fishers!!
Researchers at the University of Notre Dame discovered a new type of cell in the heart that may help regulate heart rate, and could be an important key in understanding certain types of congenital heart defects and other diseases that involve the heart.

Read More (Source: University of Notre Dame)
Congratulations to OYE Therapeutics on being one of ABL's 2021 "Innovators in Healthcare" awardee/presenters!

Brett Dines, CEO of OYE Therapeutics, knew the stats: "delayed emergence" from the coma-like state anesthesia creates contributes to over 32,000 deaths, 2.4 million extra days of post-surgical hospitalization, and $9.3 billion in added OR expenses each year. He also knew that while naloxone could ultimately keep an overdose victim from dying, they'd still need to spend hours in the ED while opioid respiratory depression continued. The good news is that Brett's team is working on the solution to both problems: formulation enhancements to an existing FDA-approved drug.
Understand What FDA Does and Does Not Want to Hear from Sponsors
Too often, sponsors and would-be drug marketers who meet with FDA make critical mistakes in terms of the information they do and do not present during the precious time they get with the Agency. For example, they may bore Agency personnel with financial data aimed at investors, try to sway them with perspectives that don’t interest the Agency, argue pointlessly, and needlessly offer information that damages their own position. Pearl Pathways has seen it all. In this first post in our “Ask the Expert” series, Bob Seevers offers some valuable insight on the “Dos” and “Do nots” of meeting with FDA. 
READ THE POST HERE (Source: Pearl Pathways)
MED Institute obtained FDA qualification of their MDDT (Medical Device Development Tool) for Virtual MRI Safety Evaluations
Read More (Source: MED Institute)
FAST Biomedical Wins Top Honors and Secures New Patent

It’s not every day your company is recognized with the prestigious Judges’ Award after being selected as the top 10% of applicants to present. Thank you to the judges panel and @OctaneOC for awarding us with the top honor at the MedTech Innovation Forum.


We are proud to announce that we’ve been awarded yet another patent for the fluorescent dyes used in our technology. The patent provides additional strength and continued protection of our plasma volume marker and serves as an important step towards revolutionizing heart failure. (Source: FAST Biomedical @FASTBiomedical)
OpenTrons – Laboratory Automation Solutions
Promotional Offer for IHIF Members: FREE pipette with OT-2 robot order!
Introducing the OT-2, your personal pipetting robot.
Lab-Crafters showcases our I-FLEX System, showing you all it can do. It truly allows for quick change as your lab requirements change.

This animated video will take you through all the features of an individual bench. 

Please reach out to Betsy Fouts with any questions, suggestions, or comments. 
Industry News
FDA Approves ‘Illuminating’ Drug for Spotting Cancer
The U.S. Food and Drug Administration on Monday approved a new imaging drug, developed by a Purdue University researcher, that can help spot tumors during surgery with the use of fluorescent technology. Cytalux is marketed by West Lafayette-based On Target Laboratories Inc. and was created by Dr. Philip Low, an icon in Indiana’s life sciences sector. The FDA approved the drug for early detection of ovarian cancer, one of the leading causes of gynecological cancer deaths. Read More (Source: Inside Indiana Business)
Fishers Attracts Another Life Sciences Company
A third life sciences company has announced plans to build a laboratory and manufacturing plant in the Fishers Life Science & Innovation Park. List Biotherapeutics Inc. says it will invest more than $125 million to establish a 110,000-square-foot contract manufacturing facility and hire 210 employees by the end of 2023.

List Bio follows in the path of life sciences firms Stevanato Group and INCOG Pharma to place facilities in the business park.

The company, a subsidiary of South Korea-based Genome & Co., specializes in biologics manufacturing. The facility would produce microbiomes, a beneficial bacteria used to target a variety of diseases or conditions.

Read More (Source: Inside Indiana Business)
Manchester to Expand Specialized Pharma Programs
Manchester University has forged a partnership with San Diego-based Agena Bioscience to expand its educational resources in the field of pharmacogenomics. Pharmacogenomics is the study of how a person’s unique genetic makeup influences his or her response to medications. Read More (Source: Inside Indiana Business)
Gener8 Has Acquired RND, Expanding Into Life Sciences Software Development
Gener8 LLC ("Gener8"), a portfolio company of Sverica Capital Management LP ("Sverica"), announced today that it has completed its acquisition of the RND Group ("RND"), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana.

With the acquisition of RND, Gener8 is adding full lifecycle software development capabilities, including cloud solutions, verification & validation, quality system compliance, LIS/EHR integration and more. The company has assembled a library of protocols that serve to accelerate the development process by leveraging pre-built core functionality. While Gener8 already provides turnkey instrument and consumable solutions, as well as accompanying firmware, the acquisition of RND enables Gener8 to extend its services off-instrument to the related software.
Read More Source: (RND and PRNewswire)
Welcome New IHIF Members and Strategic Partners!
Follow IHIF on Twitter to keep up with all of the latest news, events, and exclusive member benefits!

Featured New Member
The Indiana Center for Biomedical Innovation (ICBI) is the commercialization engine for the Indiana Clinical and Translational Sciences Initiative (CTSI). Created as a partnership between IU Health and the Indiana University School of Medicine, ICBI’s unique incubator facility offers young companies access to a vibrant entrepreneurial ecosystem with fully equipped laboratories, collaborative space, conferencing, and animal facilities. Tenant companies also have access to a host of targeted support services and resources.

Thank you to all of our 2021 renewing members!
Upcoming Events
The Indiana Health Industry Forum and Barnes & Thornburg LLP partner to present a monthly seminar series on critical issues in the life sciences. Each month a policymaker or a panel in the field of life sciences will be available to answer questions concerning the major challenges and opportunities in the industry. We hope you will join us.
Tuesday, December 21, 2021 – Live Stream or IN-PERSON (!)
LIVE location: Barnes & Thornburg, 11 S. Meridian Street, 5th floor conference room, Indianapolis, IN 46204
11:30 am – 1:00 pm

We Made It Through!
A Look at the Top Stories of 2021

2021 was (another) one for the record books – from vaccines and politics, to investments and record growth – Indiana’s life sciences sector, the state, and the country will never be quite the same. Please join us in person as we talk with industry leaders, review some of the top stories from this past year, and discuss what we might take with us into 2022.

You won’t want to miss this opportunity to network with peers over lunch and celebrate being back together for the first time since February 2020. Break out the party hats! We look forward to seeing you – either in person or via the digital option for this event! Presenters will be announced prior to the luncheon. up in 2021.
  • Kylie Veleta, Business of Health Reporter & Special Projects Editor, Inside Indiana Business 
  • Kristin Jones, President and CEO, Indiana Health Industry Forum
  • Deborah Pollack-Milgate, Partner, Barnes & Thornburg

There is no charge to attend.
COVID Care: As we gather together again, please be prepared to wear a mask as recommended. Please stay home and view on-line if you are not feeling well or have been recently exposed to someone with COVID.

Registration Now Open for Global Life Science Partnering Conference
12th Annual Global Life Science Partnering Conference

Biocom California’s 12th Annual Global Life Science Partnering Conference is returning in-person to The Lodge at Torrey Pines from February 22nd to 24th, 2022. This conference is an exclusive global partnering forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies.

This year, industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.

Event Details
When: February 22nd – February 24th, 2022
Where: The Lodge at Torrey Pines
​​​​​​11480 N Torrey Pines Rd, La Jolla, CA 92037

Save the Date for BIO 2022
Mark Your Calendar for the BIO International Convention
June 13-16, 2022, in San Diego, CA
BIO is thrilled to be back in person for the 2022 International Convention happening in San Diego, CA June 13-16. The Convention theme ‘LIMITLESS’ is our commitment to unlocking possibilities for our members and attendees while paving the path to the future of our industry.  

The BIO International Convention attracts 15,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.   

A registration discount will be available for IHIF members only - Stay tuned for additional details. Not an IHIF member? Join today!
Kelley Conference Series
Kelley IN Life Sciences
Collaboration Series
2021 – 2022 Conference Series

Since 2006, the Center for the Business of Life Sciences at the IU Kelley School of Business (CBLS) has been presenting the Indiana Life Sciences Collaboration Conference Series, providing a forum for professionals in healthcare and life sciences to consider, discuss, and debate key business strategy issues. The conferences bring together leaders from industry, academia, government, and economic development communities. Join us in exploring business solutions and making new connections in the life sciences.


The CBLS has missed gathering with corporate partners and friends in the industry! This year, in response, the plan is to offer a hybrid series – in person conferences while streaming the events so attendees may also join virtually. The registration page provides options for in person or virtual registration.

Impact of the New Administration: HHS, FDA, CMS
February 18, 2022

The Potential of AI & Smart Devices in Healthcare
April 29, 2022

BIO Business Solutions - Special Discounts for IHIF Members
BIO Business Solutions provides cost-savings offers to eligible IHIF Members. To learn more about the programs and services available, please click here. Not an IHIF member? Join today! See the latest deals and offers from our BIO Business Solutions partners here
Featured Program
About ALT
Clean Harbors is one of the largest environmental services companies in North America. Clean Harbors manages waste recycling and disposal for almost all waste streams, planned environmental and industrial services, as well as Emergency Response Services. Clean Harbors has offices throughout the United States, Canada, and Puerto Rico.

IHIF Member Benefits

  • Special pricing and discounts for members includes 35-40% off list on disposal; 15-20% off list on transportation and materials and 35% off list price on labor charges
  • Reduced Security Recovery Fee for members
  • Free site visit to ensure storage area and recordkeeping are in compliance, as well as waste stream review
  • Full Online Services capability to track waste, manage profiles, view all reporting, download biannual report data and  streamline data gathering process as well as full transparency to pricing
  • Clean Harbors will review your staff training and make recommendations to ensure you are compliant with applicable State and Federal laws

About IHIF Membership

Now is a great time to become a member of the Indiana Health Industry Forum! Join your voice to over 150 current member companies to impact the strategic direction of Indiana's health science sector.

Membership in IHIF offers a number of solutions:
  • Promote your business, locally, nationally, and globally.
  • Support the industry in the state and contribute directly to its growth and direction.
  • Find others who share your interests and build your business network.
  • Lend your voice to public policies that support innovation.
  • Directly impact your bottom line with significant savings and discount programs exclusively for IHIF members.

To complete a membership application, click here. 
Time to renew? Try it on-line! It's quick and easy! IHIF members can renew their memberships on-line at any time and update information in the Member Directory. Not an IHIF Member? Apply on-line or download an application packet now!